Forge Biologics, Case Western train gene therapy workers
Contract development and manufacturing organization Forge Biologics and Case Western Reserve University in Cleveland announced that they will collaborate on a gene therapy workforce development program. Read More
Eurekare, DNAlytics to establish AI platform for biotech startups
Eurekare has entered an agreement with DNAlytics to develop Eurekare's proprietary artificial intelligence (AI) platform to support its biotech startup studios. Read More
Unchained Labs adds nanoparticle characterization suite
Unchained Labs has launched a new application suite for the characterization of nanoparticles on Stunner, the company's gene therapy platform. Read More
Apellis, Beam to apply base editing for disease discovery
Apellis Pharmaceuticals and Beam Therapeutics announced an exclusive five-year research collaboration focused on Beam's proprietary base editing technology for the discovery of treatments for disease of the complement system. Read More
ERS Genomics licenses CRISPR tech to Nippon Gene
ERS Genomics Limited announced a nonexclusive license agreement granting Nippon Gene access to its CRISPR-Cas9 patent portfolio. Read More
Pall to develop gene therapy manufacturing platform for Exothera
Filtration, separation, and purification company Pall has signed a new $7 million contract with contract development and manufacturing organization Exothera. Read More
Twist acquires iGenomX for $35M
Twist Bioscience has acquired next-generation sequencing library preparation developer iGenomX for $35 million. The deal gives Twist a leg up in the shift from genotyping with static microarray platforms to using sequencing workflows. Read More
Antheia nabs $73M for synthetic biology platform
Antheia has raised $73 million to support the commercialization of its first pharmaceutical compound and the scale-up of production of active pharmaceutical ingredients and key starting materials on its synthetic biology platform. Read More
Boston Children's Hospital, ElevateBio partner on cell, gene therapy
Boston Children's Hospital and cell and gene therapy accelerator ElevateBio have inked a five-year collaboration to develop cell and gene therapies for patients. Read More
Ixaka, SomaLogic partner on aptamer-based, bispecific antibodies
Ixaka and SomaLogic have entered into a research collaboration to support the development of aptamer-based, bispecific therapeutics. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter